Trial Profile
Phase II clinical trial of Osmolex in Parkinson's disease patients with dyskinesia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2022
Price :
$35
*
At a glance
- Drugs Amantadine (Primary)
- Indications Dyskinesias; Parkinson's disease
- Focus Therapeutic Use
- 15 Jul 2015 New trial record